menu
About Us
Classes Of Business
HMO Reinsurance
Provider Excess Of Less
Medical Reinsurance
Employer Stop Loss
Client Captive Programs
Cell & Gene Therapy
Cost Containment
News
Contact Us
News
Bristol Myers secures another FDA go-ahead for Breyanzi, this time in mantle cell lymphoma
on
May 31, 2024
(updated July 12, 2024)
| Category:
News
Bristol Myers secures another FDA go-ahead for Breyanzi, this time in mantle cell lymphoma
Click here to download PDF
